Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PIK3CG | P48736 | 8/20 | 0.77 |
| ▸ | PIK3CA | P42336 | 6/20 | 0.70 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.69 |
| ▸ | CLK1 | P49759 | 1/20 | 0.62 |
| ▸ | DYRK1A | Q13627 | 6/20 | 0.60 |
| ▸ | NPC1 | O15118 | 2/20 | 0.59 |
| ▸ | RAB9A | P51151 | 2/20 | 0.59 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.59 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.59 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.59 |
| ▸ | FSCN1 | Q16658 | 1/20 | 0.59 |
| ▸ | PDPK1 | O15530 | 1/20 | 0.59 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.58 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.58 |
| ▸ | GLA | P06280 | 1/20 | 0.58 |
| ▸ | GAA | P10253 | 1/20 | 0.58 |
| ▸ | MAPT | P10636 | 1/20 | 0.58 |
| ▸ | HPGD | P15428 | 1/20 | 0.58 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.58 |
| ▸ | HTT | P42858 | 1/20 | 0.58 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1653742 | 0.88 | PIK3CG (0.78) | PIK3CGPIK3CACYP3A4CLK1DYRK1A | |
| SCHEMBL1651874 | 0.87 | PIK3CG (1.00) | PIK3CGPIK3CACYP3A4DYRK1ANPC1 | |
| SCHEMBL1651394 | 0.86 | PIK3CG (0.79) | PIK3CGPIK3CACYP3A4DYRK1ANPC1 | |
| SCHEMBL3716998 | 0.86 | PIK3CG (0.79) | PIK3CGPIK3CACYP3A4DYRK1ANPC1 | |
| SCHEMBL3870265 | 0.86 | PIK3CG (0.79) | PIK3CGPIK3CACYP3A4DYRK1ANPC1 | |
| SCHEMBL3711448 | 0.85 | DYRK1A (0.75) | PIK3CGPIK3CACYP3A4DYRK1ANPC1 | |
| SCHEMBL758050 | 0.85 | CLK1 (0.78) | PIK3CGPIK3CACYP3A4CLK1DYRK1A | |
| SCHEMBL798579 | 0.85 | PIK3CG (0.77) | PIK3CGPIK3CACYP3A4DYRK1ANPC1 | |
| SCHEMBL6068147 | 0.85 | ABL1 (0.79) | PIK3CGPIK3CACYP3A4NPC1RAB9A | |
| SCHEMBL20887521 | 0.84 | PIK3CG (0.70) | PIK3CGPIK3CACYP3A4DYRK1ANPC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2183232-B1 | PI3 KINASE MODULATORS AND METHODS OF USE | AMGEN INC (US) | 2013-03-06 | — | — | EP | disclosed |
| US-7928140-B2 | Benzothiazole PI3 kinase modulators for cancer treatment | AMGEN INC. (US) | 2011-04-19 | — | — | US | disclosed |
| EP-2183232-A2 | PI3 KINASE MODULATORS AND METHODS OF USE | Amgen, Inc (US) | 2010-05-12 | — | — | EP | disclosed |
| US-20090054405-A1 | PI3 kinase modulators and methods of use | AMGEN INC. (US) | 2009-02-26 | — | — | US | disclosed |
| WO-2009017822-A2 | PI3 KINASE MODULATORS AND METHODS OF USE | AMGEN INC. (US) | 2009-02-05 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090054405-A1 | PI3 kinase modulators and methods of use | PIK3CA, PIK3C2A, PIK3C2B | PIK3CG 5/4885PIK3CA 1/4885CYP3A4 3069/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.